ST
Statera Biopharma, Inc.
STAB · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Piotroski F-Score Moderate
4/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
-
N/A ROE N/A
ROA N/A
Asset turnover N/A
Debt
-
N/A Current ratio N/A
Int. coverage N/A
Net debt/EBITDA N/A
Stability
50 /100
Moderate Beta -4.78x
EPS volatility N/A
Profitable years N/A
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na STAB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Blake Hawley
Employees
46
Headquarters
Fort Collins